KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Capital Expenditures (2020 - 2025)

LifeMD (LFMD) has disclosed Capital Expenditures for 6 consecutive years, with $155454.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures rose 102.56% year-over-year to $155454.0, compared with a TTM value of $1.9 million through Dec 2025, up 27.83%, and an annual FY2025 reading of $1.9 million, up 27.83% over the prior year.
  • Capital Expenditures was $155454.0 for Q4 2025 at LifeMD, down from $797258.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $8.1 million in Q4 2022 and bottomed at -$6.1 million in Q4 2024.
  • Average Capital Expenditures over 5 years is $603652.2, with a median of $132393.0 recorded in 2023.
  • The sharpest move saw Capital Expenditures plummeted 17761.61% in 2023, then soared 5886.07% in 2024.
  • Year by year, Capital Expenditures stood at -$1.7 million in 2021, then skyrocketed by 572.99% to $8.1 million in 2022, then crashed by 98.66% to $109332.0 in 2023, then tumbled by 5663.78% to -$6.1 million in 2024, then surged by 102.56% to $155454.0 in 2025.
  • Business Quant data shows Capital Expenditures for LFMD at $155454.0 in Q4 2025, $797258.0 in Q3 2025, and -$1.8 million in Q2 2025.